by The global dermatology CRO market size accounted for US$ 5.11 Bn in 2022 and is projected to reach around USD 8.7Bn by 2030, growing at a CAGR of 6.88% from 2022 to 2030.
Report Summary
The global dermatology CRO market report provides a Point-by-Point and In-Depth analysis of global market size, regional and country-level market size, market share, segmentation market growth, competitive landscape, sales analysis, opportunities analysis, strategic market growth analysis, the impact of domestic and global market key players, value chain optimization, trade regulations, recent developments, product launches, area marketplace expanding, and technological innovations.
The study offers a comprehensive analysis on diverse features, including production capacities, demand, product developments, revenue generation, and sales in the dermatology CRO market across the globe.
A comprehensive estimate on the dermatology CRO market has been provided through an optimistic scenario as well as a conservative scenario, taking into account the sales of dermatology CRO during the forecast period. Price point comparison by region with global average price is also considered in the study.
Download Access to a Free Copy of Our Latest Sample Report@ https://www.precedenceresearch.com/sample/2403
Dermatology CRO Market Report Scope
| Report Coverage | Details |
| Market Size in 2022 | USD 5.11 Billion |
| Market Size by 2030 | USD 8.7 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 6.88% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered |
|
Key Highlights:
Reports Coverage: It incorporates key market sections, key makers secured, the extent of items offered in the years considered, worldwide containerized dermatology CRO market and study goals. Moreover, it contacts the division study gave in the report based on the sort of item and applications.
Market Outline: This area stresses the key investigations, market development rate, serious scene, market drivers, patterns, and issues notwithstanding the naturally visible pointers.
Market Production by Region: The report conveys information identified with import and fare, income, creation, and key players of every single local market contemplated are canvassed right now.
Also Read: Melt Electrowriting Technology Market Size Analysis 2022 To 2030
Dermatology CRO Market Players
The report includes the profiles of key dermatology CRO market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information, key development in past five years.
Major companies operating in this area
- IQVIA HOLDINGS INC.
- Covance Inc.
- Pharmaceutical Product Development, LLC (PPD)
- Parexel International Corporation
- Charles River Laboratories International, Inc.
- Icon, Plc
- Medidata Solutions, Inc.
- Syneos Health
- Pharmaron
- GVK Biosciences Private Limited
- Wuxi AppTec
- MEDPACE HOLDINGS, INC.
- PRA Health Sciences
- CTI Clinical Trial & Consulting
- Bioskin
- Proinnovera
- Biorasi
- Javara
- TFS
Market Segmentation
By Service
- Project Management/Clinical Supply Management
- Data Management
- Regulatory/Medical Affairs
- Medical Writing
- Clinical Monitoring
- Quality Management/Assurance
- Bio-statistics
- Investigator Payments
- Laboratory
- Patient and Site Recruitment
- Technology
- Others
By Type
- Drug Discovery
- Target Validation
- Lead Identification
- Lead optimization
- Preclinical
- Clinical
By Phase Type
- Phase I
- Phase II
- Phase III
- Phase IV
Regional Segmentation
- North America (U.S., Canada, Mexico)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
Research Methodology
Secondary Research
It involves company databases such as Hoover’s: This assists us to recognize financial information, the structure of the market participants and industry’s competitive landscape.
The secondary research sources referred in the process are as follows:
- Governmental bodies, and organizations creating economic policies
- National and international social welfare institutions
- Company websites, financial reports and SEC filings, broker and investor reports
- Related patent and regulatory databases
- Statistical databases and market reports
- Corporate Presentations, news, press release, and specification sheet of Manufacturers
Primary Research
Primary research includes face-to-face interviews, online surveys, and telephonic interviews.
- Means of primary research: Email interactions, telephonic discussions and Questionnaire-based research etc.
- In order to validate our research findings and analysis, we conduct primary interviews of key industry participants. Insights from primary respondents help in validating the secondary research findings. It also develops Research Team’s expertise and market understanding.
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Dermatology CRO Market
5.1. COVID-19 Landscape: Dermatology CRO Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Dermatology CRO Market, By Service
8.1. Dermatology CRO Market, by Service, 2022-2030
8.1.1 Project Management/Clinical Supply Management
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Data Management
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Regulatory/Medical Affairs
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Regulatory/Medical Affairs
8.1.4.1. Market Revenue and Forecast (2017-2030)
8.1.5. Clinical Monitoring
8.1.5.1. Market Revenue and Forecast (2017-2030)
8.1.6. Quality Management/Assurance
8.1.6.1. Market Revenue and Forecast (2017-2030)
8.1.7. Bio-statistics
8.1.7.1. Market Revenue and Forecast (2017-2030)
8.1.8. Investigator Payments
8.1.8.1. Market Revenue and Forecast (2017-2030)
8.1.9. Laboratory
8.1.9.1. Market Revenue and Forecast (2017-2030)
8.1.10. Clinical Monitoring
8.1.10.1. Market Revenue and Forecast (2017-2030)
8.1.11. Technology
8.1.11.1. Market Revenue and Forecast (2017-2030)
8.1.12. Clinical Monitoring
8.1.12.1. Market Revenue and Forecast (2017-2030)
8.1.13. Others
8.1.13.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Dermatology CRO Market, By Type
9.1. Dermatology CRO Market, by Type, 2022-2030
9.1.1. Drug Discovery
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Preclinical
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Clinical
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Dermatology CRO Market, By Phase Type
10.1. Dermatology CRO Market, by Phase Type, 2022-2030
10.1.1. Phase I
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Phase II
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Phase III
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Phase IV
10.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Dermatology CRO Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.2. Market Revenue and Forecast, by Type (2017-2030)
11.1.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.1.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.1.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.1.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.6.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.6.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.2.7.2. Market Revenue and Forecast, by Type (2017-2030)
11.2.7.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.6.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.6.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.3.7.2. Market Revenue and Forecast, by Type (2017-2030)
11.3.7.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.6.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.6.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Service (2017-2030)
11.4.7.2. Market Revenue and Forecast, by Type (2017-2030)
11.4.7.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.4.2. Market Revenue and Forecast, by Type (2017-2030)
11.5.4.3. Market Revenue and Forecast, by Phase Type (2017-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Service (2017-2030)
11.5.5.2. Market Revenue and Forecast, by Type (2017-2030)
11.5.5.3. Market Revenue and Forecast, by Phase Type (2017-2030)
Chapter 12. Company Profiles
12.1. IQVIA HOLDINGS INC.
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Covance Inc.
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. Pharmaceutical Product Development, LLC (PPD)
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Parexel International Corporation
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Charles River Laboratories International, Inc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. Icon, Plc
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Medidata Solutions, Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Syneos Health
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Pharmaron
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. GVK Biosciences Private Limited
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
